Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Air Products & Chemicals, Inc. (APD) vs Altria Group Inc (MO) Price & Performance

Air Products & Chemicals, Inc.Trade
Altria Group IncTrade

Price performance (Past 24H)

Key statistics

Air Products & Chemicals, Inc. vs Altria Group Inc — how do they compare? Air Products & Chemicals, Inc. trades at $306.12 (market cap $68.88B), while Altria Group Inc trades at $64.84 (market cap $108.58B). The key difference: Altria Group Inc is the larger of the two by market cap, and Altria Group Inc pays the higher dividend (6.52%). Which is the better fit depends on your goals.

APDMO
Market Cap
$68.88B$108.58B
Sector
Basic MaterialsConsumer Staples
52-Week High
$314.19$74.92
52-Week Low
$230.42$54.72
Enterprise Value
$86.06B$130.79B
Dividend Yield
2.34%6.52%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Air Products & Chemicals, Inc.

Air Products and Chemicals (APD) trades at $308.18, up 1.56% with strong technical momentum and bullish moving averages. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 EPS of $3.47 exceeding expectations. Recent positive developments include a major semiconductor supply agreement in Taiwan and raised guidance, though profitability metrics show weakness with negative net income margin and ROE. Analyst consensus remains strongly bullish with a $346 price target representing 12% upside potential.

APD presents a growth opportunity driven by strategic contracts and consistent earnings beats, but faces fundamental challenges with negative profitability and elevated debt levels. The stock's technical strength and institutional support provide near-term momentum, though investors should weigh the disconnect between valuation multiples and current financial performance against the company's long-term growth prospects in industrial gases.

Altria Group Inc

Altria Group (MO) trades at $65.54, down 4.11% amid bearish technical signals and mixed earnings performance. The stock shows strong fundamentals with a 39% net income margin and attractive 6.3% dividend yield, though cigarette volume declines persist. Recent Q2 2026 earnings missed expectations, triggering price weakness and multiple legal investigations into potential securities violations. Analyst consensus remains positive with 61.5% buy ratings and $67 price target, but technical indicators suggest near-term pressure with support at $62-65.

MO presents a value opportunity for income investors with its high yield and reasonable P/E of 13.7, though regulatory risks and declining traditional tobacco business create headwinds. The smoke-free product expansion offers growth potential, but legal uncertainties and volume erosion require careful monitoring. Current levels near support provide entry points for dividend-focused investors willing to accept sector-specific risks.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Air Products & Chemicals, Inc.

Since its founding in 1940, Air Products has become one of the leading industrial gas suppliers globally, with operations in 50 countries and 19,000 employees. The company is the largest supplier of hydrogen and helium in the world. It has a unique portfolio serving customers in a number of industries, including chemicals, energy, healthcare, metals, and electronics. Air Products generated $10.3 billion in revenue in fiscal 2021.

Read more on APD

About Altria Group Inc

Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).

Read more on MO